NOVARTIS

NOVARTIS logo
🇨🇭Switzerland
Ownership
Public, Private
Established
1996-01-01
Employees
76K
Market Cap
$242.6B
Website
https://www.novartis.com/our-science/novartis-institutes-biomedical-research

Real-world Aliskiren Use in Diabetic Patients

Completed
Conditions
First Posted Date
2011-07-13
Last Posted Date
2011-07-14
Lead Sponsor
Novartis
Target Recruit Count
200
Registration Number
NCT01393860
Locations
🇺🇸

MODEL Clinical Research, Research Division of Bay Endocrinology Associates GBMC Physicians pavilion North, Baltimore, Maryland, United States

Efficacy and Safety of Diclofenac 1.16% Gel in Subjects With Acute Neck Pain

First Posted Date
2011-04-14
Last Posted Date
2012-07-18
Lead Sponsor
Novartis
Target Recruit Count
72
Registration Number
NCT01335724
Locations
🇩🇪

NCH investigative site, Munich, Germany

Drug Use Investigation for TYKERB Tablet (All Case Investigation)

Completed
Conditions
Interventions
First Posted Date
2011-04-11
Last Posted Date
2017-04-26
Lead Sponsor
Novartis
Target Recruit Count
4054
Registration Number
NCT01332396

Efficacy of DNK333 in Patients With COPD and Cough

First Posted Date
2011-02-01
Last Posted Date
2011-02-01
Lead Sponsor
Novartis
Target Recruit Count
28
Registration Number
NCT01287325
Locations
🇬🇧

Novartis Investigative Site, London, United Kingdom

Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program

Completed
Conditions
Interventions
First Posted Date
2011-01-24
Last Posted Date
2012-09-06
Lead Sponsor
Novartis
Target Recruit Count
64
Registration Number
NCT01281657
Locations
🇺🇸

Caritas St. Elizabeth's Hospital, Boston, Massachusetts, United States

🇺🇸

Swedish Neuroscience Institute, Seattle, Washington, United States

🇺🇸

University of Miami, Miami, Florida, United States

and more 40 locations

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-01-10
Last Posted Date
2013-01-24
Lead Sponsor
Novartis
Target Recruit Count
205
Registration Number
NCT01272934
Locations
🇩🇪

NCH investigative site, Gilching, Germany

🇩🇪

NCH investigative site, Munich, Germany., Munich, Germany

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Blunt Trauma Injuries

First Posted Date
2011-01-10
Last Posted Date
2013-01-10
Lead Sponsor
Novartis
Target Recruit Count
204
Registration Number
NCT01272947
Locations
🇩🇪

NCH investigative site, Munich, Germany

Efficacy and Safety of a Sore Throat Lozenge Containing Lidocaine and Cetylpyridinium Chloride in Patients With Sore Throat Due to a Common Cold.

First Posted Date
2010-12-23
Last Posted Date
2013-04-24
Lead Sponsor
Novartis
Target Recruit Count
250
Registration Number
NCT01265446
Locations
🇩🇪

Socratec, Erfurt, Germany

A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-12-08
Last Posted Date
2014-02-10
Lead Sponsor
Novartis
Target Recruit Count
14075
Registration Number
NCT01256658
Locations
🇧🇫

Novartis Investigative site, Ouagadougou, Burkina Faso

🇧🇫

Novartis Investigative Site, Burkina Faso, Burkina Faso

🇧🇫

Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou, Burkina Faso

Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients

First Posted Date
2010-12-08
Last Posted Date
2012-06-21
Lead Sponsor
Novartis
Target Recruit Count
71
Registration Number
NCT01256294
Locations
🇺🇸

University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

🇺🇸

University of Cincinnati Medical Center, Cincinnati, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath